论文部分内容阅读
目的探讨胺碘酮联合美托洛尔治疗快速心律失常的临床效果及价值。方法方便选取该院2015年4月-2016年4月间收治的76例快速心律失常患者为研究对象,随机分为对照组和观察组各38例。给予对照组单纯的胺碘酮治疗,给予对照组胺碘酮联合美托洛尔治疗,对比两种治疗方法的临床效果差异。结果治疗后,观察组患者的窦性心律转复率、有效率及起效时间分别为94.74%、97.4%、(0.5±0.1)h,明显优于对照组,两组差异有统计学意义(P<0.05);观察组的舒张压、收缩压及心律分别为(75.1±11.2)mmHg、(116.2±15.4)mmHg、(72.1±13.7)次/min,其治疗前后的变化幅度明显大于对照组,两组差异有统计学意义(P<0.05);两组患者的不良反应发生率分别为5.3%、7.9%,差异无统计学意义(P>0.05)。结论对快速心律失常患者实施胺碘酮联合美托洛尔治疗,效果显著,值得推广和应用。
Objective To investigate the clinical effect and value of amiodarone combined with metoprolol in the treatment of tachyarrhythmias. Methods Convenient Selection of 76 patients with tachyarrhythmia admitted from April 2015 to April 2016 in our hospital were randomly divided into control group and observation group of 38 cases each. The control group was treated with amiodarone alone, and the control group received amiodarone combined with metoprolol. The difference in clinical effect between the two treatment methods was compared. Results After treatment, the rate of sinus rhythmization, effective rate and the onset time in the observation group were 94.74%, 97.4% and 0.5 ± 0.1 h, respectively, which were significantly better than those in the control group (75.1 ± 11.2) mmHg, (116.2 ± 15.4) mmHg and (72.1 ± 13.7) times / min, respectively, and the changes in the observation group before and after treatment were significantly greater than those in the control group (P <0.05). The incidences of adverse reactions in both groups were 5.3% and 7.9%, respectively, with no significant difference (P> 0.05). Conclusions Amiodarone combined with metoprolol in patients with tachyarrhythmia is effective and worthy of promotion and application.